Importer of Controlled Substances; Notice of Registration; Noramco, Inc., 23375 [2014-09573]
Download as PDF
<![CDATA[
23375
Federal Register / Vol. 79, No. 81 / Monday, April 28, 2014 / Notices
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–09573 Filed 4–25–14; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2014–09578 Filed 4–25–14; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Importer of Controlled Substances,
Notice of Registration, Myoderm
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Noramco, Inc.
By Notice dated January 14, 2014, and
published in the Federal Register on
January 22, 2014, 79 FR 3627, Noramco,
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
tkelley on DSK3SPTVN1PROD with NOTICES
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture other controlled substances
for distribution to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
in accordance with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
VerDate Mar<15>2010
17:06 Apr 25, 2014
Jkt 232001
By Notice dated December 23, 2013,
and published in the Federal Register
on January 10, 2014, 79 FR 1887,
Myoderm, 48 East Main Street,
Norristown, Pennsylvania 19401, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Nabilone (7379) ............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in finished
dosage form for clinical trials, and
research.
The import of the above listed basic
classes of controlled substances will be
granted only for analytical testing and
clinical trials. This authorization does
not extend to the import of a finished
FDA approved or non-approved dosage
form for commercial distribution in the
United States.
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Myoderm to import the basic class of
controlled substance is consistent with
the public interest and in accordance
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEA has investigated Myoderm to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–09551 Filed 4–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Mylan
Pharmaceuticals, Inc.
By Notice dated November 12, 2013,
and published in the Federal Register
on November 19, 2013, 78 FR 69447,
Mylan Pharmaceuticals, Inc., 781
Chestnut Ridge Road, Morgantown,
West Virginia 26505, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Methadone (9250) ........................
Morphine (9300) ...........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mylan Pharmaceuticals, Inc., to import
the basic classes of controlled
substances is consistent with the public
E:\FR\FM\28APN1.SGM
28APN1
]]>Agencies
[Federal Register Volume 79, Number 81 (Monday, April 28, 2014)]
[Notices]
[Page 23375]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09573]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Noramco, Inc.
By Notice dated January 14, 2014, and published in the Federal
Register on January 22, 2014, 79 FR 3627, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture other controlled substances for distribution to its
customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417, (January 25,
2007).
No comments or objections have been received. The DEA has
considered the factors in 21 U.S.C. 823(a) and 952(a) and determined
that the registration of Noramco, Inc. to import the basic classes of
controlled substances is consistent with the public interest and in
accordance with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971. The DEA has
investigated Noramco, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic classes of controlled substances listed.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-09573 Filed 4-25-14; 8:45 am]
BILLING CODE 4410-09-P
